Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) will release its third quarter 2025 financial results on Wednesday, October 29, 2025 after market close.
The company will host a conference call at 4:30 PM ET on October 29, 2025 to discuss the results and corporate activities; domestic dial-in is 1-888-596-4144, international 1-646-968-2525, passcode 8728050. A simultaneous webcast will be available and archived on www.vandapharma.com; investors should access the site at least 15 minutes early to register and install audio software.
A replay will be available beginning October 29, 2025 at 8:30 PM ET through November 5, 2025 at 11:59 PM ET; replay domestic number 1-800-770-2030, international 1-609-800-9909, passcode 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA) presenterà i dati finanziari del terzo trimestre 2025 il mercoledì 29 ottobre 2025 dopo la chiusura del mercato.
La società terrà una conferenza telefonica alle ore 16:30 ET il 29 ottobre 2025 per discutere i risultati e le attività aziendali; il numero di accesso domestico è 1-888-596-4144, internazionale 1-646-968-2525, codice di accesso 8728050. Una trasmissione web contemporanea sarà disponibile e archiviata su www.vandapharma.com; gli investitori dovrebbero accedere al sito almeno 15 minuti prima per registrarsi e installare il software audio.
Una replica sarà disponibile a partire dal 29 ottobre 2025 alle 16:30 ET fino al 5 novembre 2025 alle 23:59 ET; numero di replica domestico 1-800-770-2030, internazionale 1-609-800-9909, codice di accesso 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA) publicará sus resultados financieros del tercer trimestre de 2025 el miércoles 29 de octubre de 2025 tras el cierre del mercado.
La empresa organizará una llamada de conferencia a las 4:30 p.m. ET el 29 de octubre de 2025 para discutir los resultados y las actividades corporativas; la línea de marcación nacional es 1-888-596-4144, internacional 1-646-968-2525, código de acceso 8728050. Habrá una transmisión simultánea en web disponible y archivada en www.vandapharma.com; los inversionistas deben acceder al sitio al menos 15 minutos antes para registrarse e instalar el software de audio.
Una repetición estará disponible a partir del 29 de octubre de 2025 a las 4:30 p.m. ET hasta el 5 de noviembre de 2025 a las 11:59 p.m. ET; número de repetición doméstico 1-800-770-2030, internacional 1-609-800-9909, código de acceso 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA)은 2025년 3분기 재무 실적을 2025년 10월 29일 수요일 장 마감 후에 발표합니다.
회사는 동시 컨퍼런스 콜을 4:30 PM ET에 2025년 10월 29일에 개최하여 결과 및 기업 활동에 대해 논의합니다; 국내 다이얼인 번호는 1-888-596-4144, 국제는 1-646-968-2525, 패스코드 8728050입니다. 동시 웹캐스트가 제공되며 www.vandapharma.com에 아카이브가 남습니다; 투자자들은 15분 일찍 사이트에 접속하여 등록 및 오디오 소프트웨어 설치를 해야 합니다.
리플레이는 2025년 10월 29일 16:30 ET부터 2025년 11월 5일 23:59 ET까지 이용 가능하며, 국내 재강번호 1-800-770-2030, 국제 1-609-800-9909, 패스코드 8728050입니다.
Vanda Pharmaceuticals (Nasdaq: VNDA) publiera ses résultats financiers du troisième trimestre 2025 le mercredi 29 octobre 2025 après la clôture du marché.
L’entreprise organisera une conférence téléphonique à 16 h 30 HE le 29 octobre 2025 pour discuter des résultats et des activités de l’entreprise ; le numéro d’accès national est 1-888-596-4144, international 1-646-968-2525, code d’accès 8728050. Une webdiffusion simultanée sera disponible et archivée sur www.vandapharma.com; les investisseurs doivent accéder au site au moins 15 minutes à l’avance pour s’enregistrer et installer le logiciel audio.
Une rediffusion sera disponible à partir du 29 octobre 2025 à 16 h 30 HE jusqu’au 5 novembre 2025 à 23 h 59 HE; numéro de rediffusion domestique 1-800-770-2030, international 1-609-800-9909, code d’accès 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA) wird seine Finanzergebnisse zum dritten Quartal 2025 am Mittwoch, dem 29. Oktober 2025 nach Börsenschluss veröffentlichen.
Das Unternehmen wird am 4:30 PM ET am 29. Oktober 2025 eine Telefonkonferenz abhalten, um die Ergebnisse und unternehmensbezogenen Aktivitäten zu besprechen; nationale Teilnahme unter 1-888-596-4144, international 1-646-968-2525, Kurzpasswort 8728050. Eine gleichzeitige Webcast wird verfügbar sein und unter www.vandapharma.com archiviert; Investoren sollten 15 Minuten früher die Website aufrufen, um sich zu registrieren und Audio-Software zu installieren.
Eine Wiederholung wird verfügbar sein ab dem 29. Oktober 2025 um 16:30 ET bis zum 5. November 2025 um 23:59 ET; Wiederholungsnummer domestic 1-800-770-2030, international 1-609-800-9909, Passcode 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA) ستصدر نتائجها المالية للربع الثالث من عام 2025 في الأربعاء 29 أكتوبر 2025 بعد إغلاق السوق.
ستعقد الشركة مكالمة مؤتمرات هاتفية في الساعة 4:30 م بتوقيت شرق الولايات المتحدة في 29 أكتوبر 2025 لمناقشة النتائج والأنشطة المؤسسية؛ رقم الاتصال المحلي 1-888-596-4144، الدولي 1-646-968-2525، وكود الدخول 8728050. سيكون هناك بث ويب متماثل متاح ومؤرشف على www.vandapharma.com؛ يجب على المستثمرين الوصول إلى الموقع قبل 15 دقيقة على الأقل للتسجيل وتثبيت برمجيات الصوت.
سيكون هناك تشغيلReplay متاح ابتداءً من 29 أكتوبر 2025 الساعة 4:30 م بتوقيت شرق الولايات المتحدة حتى 5 نوفمبر 2025 الساعة 11:59 م بتوقيت شرق الولايات المتحدة؛ رقم إعادة التشغيل المحلي 1-800-770-2030، الدولي 1-609-800-9909، وكود الدخول 8728050.
Vanda Pharmaceuticals (Nasdaq: VNDA) 将在 2025 年 10 月 29 日，周三 收盘后发布 2025 第三季度 财务业绩。
公司将于 美东时间 4:30 PM 举行 电话会议，讨论业绩及公司事宜；国内拨号＜>1-888-596-4144，国际拨号 1-646-968-2525，密钥 8728050。同时将提供网页直播，並在 www.vandapharma.com 存档；投资者请至少提前 15 分钟进入网站注册并安装音频软件。
回放将从 2025 年 10 月 29 日 16:30（ET）起至 2025 年 11 月 5 日 23:59（ET）结束；回放国内号码 1-800-770-2030，国际号码 1-609-800-9909，密钥 8728050。
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Wednesday, October 29, 2025, during which management will discuss the third quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8728050.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, October 29, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, November 5, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8728050.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2025-financial-results-on-october-29-2025-302591878.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda (VNDA) release third quarter 2025 results?
What time is the Vanda (VNDA) conference call for Q3 2025 and how do I join?
Where can investors watch the Vanda (VNDA) webcast for the October 29, 2025 call?
When and how can I access the replay of Vanda (VNDA) Q3 2025 call?
Do I need to install software to join Vanda's (VNDA) webcast?
What topics will Vanda (VNDA) management discuss on the October 29, 2025 call?
